Global Injectable Hyaluronic Acid and Botulinum Toxin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Injectable Hyaluronic Acid and Botulinum Toxin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Dermal fillers can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery. Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Injectable Hyaluronic Acid and Botulinum Toxin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Injectable Hyaluronic Acid and Botulinum Toxin market is projected to reach US$ 23550 million in 2029, increasing from US$ 11220 million in 2022, with the CAGR of 10.3% during the period of 2024 to 2029. Demand from Cosmetic and Medical are the major drivers for the industry.
Growing life expectancy has increased the average age of the population around the world. Because of the growing age of the population, there is increased importance for aesthetics and good looks, which has directly affected the need for skin fillers and botulinum toxin treatments positively.Botox injections help by blocking neurotransmitters that carry pain signals to the brain. Thus, they have been proven significant in decreasing the frequency and duration of migraine in many patients. With increasing cases of stress-triggered migraine and cluster headaches, there has been a significant positive impact on the growth of botulinum toxin injection procedures and Botox treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Injectable Hyaluronic Acid and Botulinum Toxin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA
Segment by Type
Injectable Hyaluronic Acid
Botulinum Toxin
Cosmetic
Medical
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Injectable Hyaluronic Acid and Botulinum Toxin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Injectable Hyaluronic Acid and Botulinum Toxin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Injectable Hyaluronic Acid and Botulinum Toxin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Injectable Hyaluronic Acid and Botulinum Toxin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Injectable Hyaluronic Acid and Botulinum Toxin introduction, etc. Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Injectable Hyaluronic Acid and Botulinum Toxin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Injectable Hyaluronic Acid and Botulinum Toxin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Injectable Hyaluronic Acid and Botulinum Toxin market is projected to reach US$ 23550 million in 2029, increasing from US$ 11220 million in 2022, with the CAGR of 10.3% during the period of 2024 to 2029. Demand from Cosmetic and Medical are the major drivers for the industry.
Growing life expectancy has increased the average age of the population around the world. Because of the growing age of the population, there is increased importance for aesthetics and good looks, which has directly affected the need for skin fillers and botulinum toxin treatments positively.Botox injections help by blocking neurotransmitters that carry pain signals to the brain. Thus, they have been proven significant in decreasing the frequency and duration of migraine in many patients. With increasing cases of stress-triggered migraine and cluster headaches, there has been a significant positive impact on the growth of botulinum toxin injection procedures and Botox treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Injectable Hyaluronic Acid and Botulinum Toxin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AbbVie
Galderma
LG Life Sciences
Merz
Medytox
Hugel
Croma-Pharma
Beijing IMEIK
Bloomage Bio
Elravie (Humedix)
Cleviel (Pharma Research Products)
Haohai Biological
Teoxane
Sinclair
Suneva Medical
CG Bio
SciVision Biotech
Prollenium
Bohus BioTech
Caregen
Ipsen
LIBP
US World Meds
Daewoong
JETEMA
Segment by Type
Injectable Hyaluronic Acid
Botulinum Toxin
Segment by Application
Cosmetic
Medical
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Injectable Hyaluronic Acid and Botulinum Toxin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Injectable Hyaluronic Acid and Botulinum Toxin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Injectable Hyaluronic Acid and Botulinum Toxin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Injectable Hyaluronic Acid and Botulinum Toxin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Injectable Hyaluronic Acid and Botulinum Toxin introduction, etc. Injectable Hyaluronic Acid and Botulinum Toxin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Injectable Hyaluronic Acid and Botulinum Toxin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices